医師間で放射線治療計画を共有する新しい方法、CORRECT試験 (CORRECT)
輪郭標的の評価における放射線科医と放射線腫瘍医の協働腫瘍学 (CORRECT)
This clinical trial tests a new way to share radiation therapy plans using the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow to improve communication and collaboration between radiation oncologists (ROs) and radiologists when determining cancer targets for radiation treatment. Systemic barriers limit critical communication between radiation oncologists and radiologists and can lead to both under and overdosing of radiation therapy (RT) tumor targets and failures to properly interpret post-treatment imaging. The limited formal diagnostic radiology training of many providers can make differentiating normal from disease imaging findings during target determination difficult, especially in complex disease sites like the lung, head, and neck. Inaccurate target determination may result in cancer return, excess toxicity, or both. Likewise, radiologists who cannot access prior RT plans may mistake expected RT changes for recurrent cancer or overlook true progression. The CORRECT workflow was developed by ROs and radiologists to address RO-radiology communication barriers by facilitating sharing of comprehensive RT target contours during RT planning. The CORRECT workflow begins with the normal process of RO target contouring. Computed tomography (CT) images are then fused with RT targets and pushed to a pre-designated Picture Archiving and Communications System (PACS) software folder accessible by the radiology department. The radiologist can then review the fused images at their chosen time and annotate images to indicate potential deviations (e.g., not avoiding normal tissue or not including all tumor). The RO reviews the annotated images and decides if any changes to treatment targets are needed for the final treatment plan. Through this independent, asynchronous review of high-quality images, CORRECT overcomes many of the limitations of existing communication methods between RO-radiologist, fostering a more collaborative, efficient, and precise approach to cancer treatment planning.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
PRIMARY OBJECTIVE:
To determine the feasibility of the CORRECT workflow, defined as the return of radiology feedback via CORRECT within 2 business days from receipt of initial RT targets.
SECONDARY OBJECTIVES:
I. To further assess the feasibility of the CORRECT workflow as measured by 1) time (in business days) required to install the information technology (IT) application at each practice, 2) the number and proportion of cases per practice with reports of technical issues requiring centralized IT or CORRECT study team assistance, 3) percentage of approached patients who declined consent.
II. To assess ROs and radiologists' perceptions of acceptability, appropriateness and feasibility of the CORRECT workflow using the Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and Feasibility of Intervention Measure (FIM), along with the acceptability of CORRECT workflow training.
III. To identify facilitators and barriers to radiation oncology-radiology standard of care collaboration, CORRECT workflow implementation, and participation in the future trial using a qualitative interview.
OUTLINE:
ROs and radiologists receive training on the use of the CORRECT workflow and practice with test cases. ROs and radiologists then use the CORRECT workflow with patient cases for 12 months
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Karen Craver
- 電話番号:336-716-0891
- メール:NCORP@wfusm.edu
研究場所
-
-
North Carolina
-
Winston-Salem、North Carolina、アメリカ、27157
- Wake Forest NCORP Research Base
-
コンタクト:
- Kathryn E Weaver, PhD
- 電話番号:336-716-0891
- メール:kathryn.weaver@wfusm.edu
-
コンタクト:
- Karen T Craver, MT
- 電話番号:3367160891
- メール:karen.craver@advocatehealth.org
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- PRACTICE: Must provide radiation therapy for ≥ 3 patients per month with lung cancer or head & neck cancer
- PRACTICE: At least one radiation oncologist and one radiologist (in house, contracted, etc.) at the practice willing to participate, but may have multiple participants at the practice
- PRACTICE: Radiation oncologist/radiologist team must use Picture Archiving and Communication System (PACS) software at this practice
- RADIATION ONCOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months
- RADIATION ONCOLOGIST (NON-PATIENT): Must treat lung and/or head & neck cancer patients with curative intent radiation therapy
- RADIATION ONCOLOGIST (NON-PATIENT): Willing and able to participate in 15 minutes of mandatory virtual CORRECT training
- RADIATION ONCOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study
- RADIOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months
- RADIOLOGIST (NON-PATIENT): Agree to review pre-treatment radiation therapy targets during the course of the study duration (approximately 12 months). Willing and able to participate in 15 minutes of mandatory virtual CORRECT training
- RADIOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study
- PATIENT: Must have any stage of clinically diagnosed lung or head & neck (HN) cancer
- PATIENT: Planned treatment with curative intent definitive RT (with or without other treatments). Curative intent RT must be documented in the electronic medical record (EMR) by the treating radiation oncologist
- PATIENT: Must be expected to be treated by a radiation oncologist participating in this study
- PATIENT: Must be 18 years or older
Exclusion Criteria:
- PRACTICE: Participation by the Community Site or Academic Community Site in another National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Cancer Care Delivery Research (CCDR) U34-supported protocol funded in NCI fiscal year 2025 or later. (Note: WF- 2301CD CONNECT is exempt from this policy, as it was funded prior to NCI fiscal year 2025.)
- RADIATION ONCOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months
- RADIATION ONCOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers)
- RADIOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months
- RADIOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers)
- PATIENT: Unable to understand English or Spanish
- PATIENT: Early glottic larynx cancer planned for definitive RT alone
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:Health Services Research (CORRECT workflow)
ROs and radiologists receive training on the use of the CORRECT workflow and practice with test cases. ROs and radiologists then use the CORRECT workflow with patient cases for 12 months. |
Ancillary studies Ancillary studies Ancillary studies Receive training and practice cases on CORRECT workflow Use CORRECT workflow |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The return of radiology feedback via Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) (feasibility)
時間枠:Within 2 business days from receipt of initial radiation therapy (RT) targets
|
If > 50% of patients have target feedback returned to the radiation oncologist within 2 business days, this workflow will be considered feasible in community practice. |
Within 2 business days from receipt of initial radiation therapy (RT) targets
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Time (in business days) required to install the information technology (IT) application
時間枠:During study start-up prior to the enrollment of first patient case; up to 60 days after CIRB approval at the practice.
|
Will be assessed at each practice as tracked on the CORRECT IT data form |
During study start-up prior to the enrollment of first patient case; up to 60 days after CIRB approval at the practice.
|
|
The number and proportion of cases per practice with reports of technical issues requiring centralized IT or CORRECT study team assistance
時間枠:During RT planning for each patient; over the 9 months of of patient accrual
|
Will be assessed at each practice as tracked on the CORRECT IT data form. |
During RT planning for each patient; over the 9 months of of patient accrual
|
|
Percentage of approached patients who declined consent
時間枠:During screening and enrollment over the 9 months of patient accrual
|
Will be assessed at each practice as tracked on the Patient Refusal form. |
During screening and enrollment over the 9 months of patient accrual
|
|
Acceptability of the CORRECT workflow.
時間枠:Up to 2 months after patient enrollment has concluded
|
Will be assessed using the Acceptability of Intervention Measure. Will be collected on the post-study radiation oncologist/radiologist survey. Scale has four items measured on a Likert scale from 1 (completely disagree) to 5 (completely agree). The four items are averaged to obtain a final score. |
Up to 2 months after patient enrollment has concluded
|
|
Appropriateness of the CORRECT workflow
時間枠:Up to 2 months after patient enrollment has concluded
|
Will be assessed using the Intervention Appropriateness Measure. Will be collected on the post-study radiation oncologist/radiologist survey. Scale has four items measured on a Likert scale from 1 (completely disagree) to 5 (completely agree). The four items are averaged to obtain a final score. |
Up to 2 months after patient enrollment has concluded
|
|
Feasibility of the CORRECT workflow
時間枠:Up to 2 months after patient enrollment has concluded
|
Will be assessed using the Feasibility of Intervention Measure. Will be collected on the post-study radiation oncologist/radiologist survey. Scale has four items measured on a Likert scale from 1 (completely disagree) to 5 (completely agree). The four items are averaged to obtain a final score. |
Up to 2 months after patient enrollment has concluded
|
|
Facilitators and barriers to radiation oncology-radiology standard of care collaboration, CORRECT workflow implementation, and participation in the future trial
時間枠:Up to 2 months after patient enrollment has concluded
|
Will be identified using qualitative interviews using the radiation oncologist/radiologist interview guide. |
Up to 2 months after patient enrollment has concluded
|
協力者と研究者
協力者
協力者
捜査官
捜査官
- スタディチェア:Kathryn Weaver, PhD、Wake Forest University Health Sciences
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- IRB00141160
- P30CA012197 (米国 NIH グラント/契約)
- UG1CA189824 (米国 NIH グラント/契約)
- U34CA297499 (米国 NIH グラント/契約)
- NCI - 2025-07036 (その他の識別子:NCI Trial Identifier)
- WF-2402CD (その他の識別子:CTEP Identifier)
- WF-2402CD (その他の識別子:Lead Organization Identifier)
- WF-2402CD (その他の識別子:DCP Identifier)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.
IPD 共有時間枠
6 months after publication for a 2 year duration
IPD 共有アクセス基準
upon request to NCORP@wfusm.edu
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。